Network Meta-Analysis Ranks GLP-1 Agonists by Composite Cardiometabolic Benefit Across 13,000 Adults
With GLP-1 receptor agonists now crowding the market in both injectable and oral forms, clinicians and patients face a real dilemma: which formulation…